Jianjian Medical: A Decade-Long Pioneer in Grassroots Digital Healthcare Unveils IPO Prospectus

As OpenAI-Health, Ant Group’s Afu, Baidu’s Wenxin Health Assistant, and JD Kangkang rapidly integrate into daily life, and as internet giants collectively deploy AI health agents, the era of digital-intelligent healthcare has fully arrived. Leveraging their traffic, technology, and ecosystems, these tech titans have brought health consultations, medical examination interpretations, and pharmaceutical services to everyone’s fingertips, unlocking a new landscape in the trillion-dollar health market. This marks both societal progress and the starting point for industrial evolution. Beyond traffic and user entry points, a more fundamental, long-term, and defensible value stronghold is being re-recognized: grassroots digital-intelligent medical care. Shunning the spotlight and independent of traffic-driven frenzies, it undertakes the final fulfillment of health services, closes the data loop, and implements policy mandates, thereby becoming an indispensable core support for the entire health ecosystem.

Undoubtedly,Public medical and health institutions will remain the absolute mainstay of primary healthcare management and public health services for a considerable period., the platform model cannot replace the primary role and offline fulfillment capabilities of grassroots public institutions. Therefore, specialized and digital-intelligent empowerment for grassroots public institutions remains an essential and indispensable industry requirement for internet health platformsIt is imperative to rely on ecosystem partners with deep grassroots penetration, strong execution capabilities, and robust compliance frameworks to truly close the service loop.。

AI is reshaping the health industry. Over the past two years, tech giants have concentrated their efforts on consumer-facing health entry points, upgrading “low-frequency medical visits” into “high-frequency health management,” making consultations, interpretation of results, reminders, and medication purchases readily accessible. As a result, user bases and market enthusiasm have continued to surge. However, the complete logic of the industry extends far beyond “entry points and interactions”: user inquiries at these entry points require professional services to follow through; generated health data demands standardized collection and governance; needs related to chronic diseases and public health necessitate practical implementation and long-term intervention; and policy and regulatory requirements call for compliant closed-loop systems and quantifiable outcomes. This means that the more prosperous the consumer-facing entry points become, the scarcer and more valuable grassroots digital-intelligent infrastructure becomes.

Even as internet platforms extend their services to the grassroots level, the pivotal role of public primary healthcare institutions remains unchanged. Platforms cannot independently carry out core tasks such as public health service delivery, chronic disease follow-up, family doctor contract signing, and clinical care fulfillment. Instead, they must rely on professional expertise to enhance the quality and efficiency of these public primary healthcare institutions, making digital-intelligence healthcare providers deeply rooted in grassroots settings an indispensable key link within the platform ecosystem. Currently, primary healthcare still faces three major core bottlenecks:

● Efficiency Bottlenecks: Primary care physicians expend substantial energy on data entry, manual follow-ups, and ledger organization, thereby compromising their clinical and service delivery capabilities;

● Capability Bottleneck: High prevalence of chronic diseases, multimorbidity, and imprecise interventions; insufficient standardization of primary care services and inadequate standardized management;

● Closed-Loop Bottleneck: Family doctor contracting, public health services, and health management are difficult to implement, with data silos, inefficient workflows, and unquantifiable outcomes.

These scenarios are strongly policy-driven, have long implementation cycles, and feature high operational barriers, requiring long-term commitment, in-depth understanding, and continuous iteration; they cannot be quickly addressed through short-term traffic and resources.

In the current medical AI landscape, two distinct camps have emerged:Platform Traffic FactionwithVertical Specialists。

Platform Traffic Faction

● Core: Seize the primary consumer-facing health entry point, drive traffic, build an ecosystem, and establish a closed-loop integration of healthcare, pharmaceuticals, and insurance;

● Advantages: Large user base, rapid reach, smooth user experience, and ample capital;

● Weaknesses: Insufficient depth at the grassroots level, weak medical professionalism, high compliance pressure, and profit reliance on drug sales/insurance; unable to independently meet the primary fulfillment demands of grassroots public institutions;

● Logic: High-frequency engagement, free customer acquisition, long-term monetization.

Vertical Specialists

● Core: Deeply cultivate the B2B and G2B sectors, focusing on digital-intelligent transformation at the primary care level, chronic disease management, public health quality improvement, and tiered diagnosis and treatment.

● Advantages: High alignment with policy, deep professional barriers, data compliance and security, robust business model, and healthy cash flow; it is the core force empowering grassroots public healthcare institutions as the mainstay and meeting platform implementation needs.

● Weaknesses: Low public visibility, expansion driven by operations, and growth that is certain but moderate;

● Logic: Solution-driven, integrated hardware and software, in-depth operations, long-term services.

Countless facts have proven that there are no shortcuts in primary healthcare. Most companies have a simplistic and crude understanding of primary care informatization projects—building platforms, deploying systems, and leaving once delivery is complete. In contrast, Jianjian Medical has been firmly committed from day one to addressing weaknesses, building closed-loop systems, engaging in deep operational management, and maintaining a long-term commitment.

A Decade of Deep Cultivation: Jianjian Has Forged an Inimitable Path to Breakthroughs—Entering via Digital Public Health, Empowering Chronic Disease Management with AI, Driving Implementation through Operations, and Creating Value through Closed-Loop Systems.

1. Addressing Weaknesses: Three Core Competencies to Resolve Pain Points at the Grassroots Level

● Addressing gaps in digital intelligence: Digital public health examination workstations and digitalized mobile examination vehicles enable real-time data collection and intelligent analysis, improving efficiency by over 80% and reducing the error rate to below 0.5%, thereby extending service coverage to remote villages.

● Addressing gaps in chronic disease management: Developed China’s first AI-powered family doctor agent (JJGPT), leveraging a dual-physician collaborative model of “AI physicians + human physicians” to establish a closed-loop, full-cycle chronic care system encompassing prevention, screening, diagnosis, treatment, management, and rehabilitation, thereby standardizing and enabling practical implementation of management for major chronic conditions such as hypertension and diabetes.

● Bridging Technical Capability Gaps: The “AI Digital-Intelligent Health Brain” integrates the DeepSeek large language model with Retrieval-Augmented Generation (RAG) technology, internalizing public health standards, clinical guidelines, and expert consensus into traceable and verifiable AI capabilities. This ensures that primary care diagnosis and treatment are evidence-based, standardized, and quantifiable. Notably, the integrated digital-intelligent solution for stroke prevention, emergency treatment, and rehabilitation—jointly developed by Jianjian Medical and top-tier institutions such as Capital Medical University and Fudan University—has passed the scientific and technological achievement evaluation by the Ministry of Industry and Information Technology, reaching an internationally advanced level and filling the gap in corresponding technologies at the primary care level.

2. Building Barriers: Integrated Hardware-Software Solutions and In-Depth Operations to Establish a Moat Difficult for Competitors to Replicate

The moat of Jianjian has never been based on a single technology, but rather on its business model.

● Barrier 1: Integrated software and hardware, bridging the last mile of data collection. Rather than operating as a pure software vendor, we extend our software capabilities through intelligent hardware, addressing at the source the challenges of inefficient manual entry, inaccurate data, and information silos.

● Barrier 2: Deep operational engagement—delivery is not the end, but the beginning of service. From process optimization and staff training to daily operations and quality supervision, we are deeply involved in reshaping grassroots healthcare services. Our services cover over 300 districts/counties and more than 3,000 township/community hospitals across China. This heavy-operation, strong-implementation capability constitutes a core asset that tech giants focused on traffic and pure technology companies cannot surpass in the short term.

3. Demonstrated Effectiveness: Ten Years of Data Speak, from Pilot Projects to a National Benchmark

No stories, just results:

● Coverage scale: 40,000+ family doctor teams, serving over 80 million elderly individuals aged 60 and above;

● Qualifications and Honors: Recognized as a National Specialized, Refined, Differential, and Innovative “Little Giant” enterprise in the fourth and seventh batches; holds 47 granted patents and 161 software copyrights.

● Industry Standard: In 2022, we spearheaded the release of China’s first group standard for the public health examination industry, defining the industry through standardization;

● Financial Performance: Cumulative net profit over the past three years has reached tens of millions of yuan, with 2025 revenue exceeding RMB 150 million and per-capita revenue generation far surpassing the industry average. In a healthcare sector widely characterized by heavy cash burn, Jianjian Medical has achieved high-quality, sustainable profitability.

For investors in the healthcare sector, companies across the upstream and downstream industry chains, and ecosystem partners, the value of Jianjian Medical is clear and measurable:

1. Highly certain market segment

● Strong Policy Support: Healthy China, strengthening primary care, tiered diagnosis and treatment, integration of medical care and prevention, and chronic disease management are all national long-term strategies;

● Inelastic Demand: Accelerating population aging, high prevalence of chronic diseases, and improvements in public health quality are driving continuous market expansion;

● Regulatory-friendly: Deeply engaged in the business-to-government (B/G) sector, with a robust compliance framework and controllable risks.

2. Sustainable Business Model

● Product Revenue: Integrated software-hardware digital intelligence devices, AI platform systems;

● Service revenue: public health operations, family doctor contracting, and chronic disease management services;

● Ecological Revenue: Medical consortium development, technology empowerment, standard export, and collaborative services.

Diversified structure, independence, and counter-cyclicality: achieving steady growth in a slow-moving industry.

3. Outstanding Strategic Synergy Value

● Provide digital intelligence and operational empowerment to grassroots public healthcare institutions, strengthening the foundation of services and enhancing execution efficiency;

● Provide grassroots fulfillment capabilities to major internet health platforms, bridging the last mile of service delivery;

● Provide a standardized health data foundation for ecosystem partners to enhance the accuracy and professionalism of AI services;

● Provide health authorities with digital and intelligent tools that are monitorable, quantifiable, and assessable, facilitating policy implementation.

2016–2026: A Decade of Sharpening One Sword. From pioneering digital public health to becoming a benchmark for intelligent grassroots healthcare, Jianjian Medical has consistently remained beyond the fleeting hype, rooting itself in the most challenging, difficult, and essential capillaries of primary care. Over ten years, we have proven that intelligent grassroots healthcare is the strongest foundation for a Healthy China, and that long-termism is the most reliable formula for success in the medical and health industry. We firmly believe that trends will fade, but professionalism endures; traffic fluctuates, but moats remain solid; short-term noise may be loud, but true value is revealed over the long term.

A Decade of Progress, Embarking on a New Journey in Health. Jianjian Medical is committed to walking alongside partners who believe in long-termism, focus on professional value, and are deeply engaged in the health industry, moving forward together toward a shared future and reaping the long-term benefits of digital and intelligent healthcare at the grassroots level.